Evaluation of Group C Meningococcal Polysaccharide Vaccine in Marine Recruits, San Diego, California

Abstract

Group C meningococcal polysaccharide vaccine was well tolerated by 3, 018 vaccinated Marine recruits. The vaccine appeared to be group-specific since it prevented the acquisition of only group C meningococci. The vaccine stimulated a good hemagglutinating antibody response, but did not stimulate a complement fixing antibody response. One systemic illness of uncertain etiology, possibly vaccine related, was observed among the vaccines. That the vaccine affords protection against clinical disease was suggested when three cases of meningococcal disease of group C etiology developed in the nonvaccinated controls while none occurred among the vaccinated men of the study population.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Dec 29, 1969
Accession Number
AD0769364

Entities

People

  • Earl A. Edwards
  • Leonard F. Devine
  • Solon L. Rhode
  • Thomas M. Floyd
  • Willard E. Pierce

Tags

DTIC Thesaurus Topics

  • Acquisition
  • Antibodies
  • Biomedical Research
  • Diseases And Disorders
  • Great Lakes
  • Health Services
  • Immune Serums
  • Immunity
  • Infection
  • Medical Personnel
  • Navy
  • Preventive Medicine
  • Surveys
  • Test And Evaluation
  • Training
  • Vaccination
  • Vaccines

Fields of Study

  • Biology
  • Medicine

Readers

  • Immunology
  • Naval Personnel Management

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech